Adaptation of International Guidelines for Metastatic Colorectal Cancer: An Asian Consensus

This publication has 24 references indexed in Scilit:

• Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012
  The Lancet Oncology, 2012
• ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
  Annals of Oncology, 2012
• The Oncosurgery Approach to Managing Liver Metastases from Colorectal Cancer: A Multidisciplinary International Consensus
  The Oncologist, 2012
• Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters
  Cancer Chemotherapy and Pharmacology, 2012
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
  International Journal of Cancer, 2010
• Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer—an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009
  Annals of Oncology, 2010
• Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
  The Lancet Oncology, 2009
• Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
  Journal of Clinical Oncology, 2007
• Increasing incidence of colorectal cancer in Asia: implications for screening
  The Lancet Oncology, 2005
• FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
  Journal of Clinical Oncology, 2004